出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/04/05 21:59:01」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
  • Lisenko K1, Baertsch MA1, Meiser R1, Pavel P2, Bruckner T3, Kriegsmann M4, Schmitt A1, Witzens-Harig M1, Ho AD1, Hillengass J1, Wuchter P5.
  • Transfusion.Transfusion.2017 Oct;57(10):2359-2365. doi: 10.1111/trf.14211. Epub 2017 Jun 26.
  • PMID 28653421
  • Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database.
  • Tilleul P1, Jacot W2, Emery C3, Lafuma A3, Gourmelen J4.
  • Journal of medical economics.J Med Econ.2017 Sep 4:1-7. doi: 10.1080/13696998.2017.1366324. [Epub ahead of print]
  • PMID 28795868
  • Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.
  • Farhan R1, Urbanowska E1, Zborowska H2, Król M1, Król M1, Torosian T3, Piotrowska I3, Bogusz K2, Skwierawska K2, Wiktor-Jędrzejczak W1, Snarski E4.
  • Annals of hematology.Ann Hematol.2017 Aug 11. doi: 10.1007/s00277-017-3060-4. [Epub ahead of print]
  • PMID 28801752


  • Hepatic Drug Interaction Between Tacrolimus and Lansoprazole in a Bone Marrow Transplant Patient Receiving Voriconazole and Harboring CYP2C19 and CYP3A5 Heterozygous Mutations
  • Iwamoto Takuya,Monma Fumihiko,Fujieda Atsushi,Nakatani Kaname,Katayama Naoyuki,Okuda Masahiro
  • CLINICAL THERAPEUTICS 33(8), 1077-1080, 2011-08
  • … Other drugs taken were acyclovir, ursodeoxycholic acid, cefepime, meropenem, vancomycin, lenograstim and dopamine hydrochloride. …
  • NAID 120005133377
  • Inductive Potential of Recombinant Human Granulocyte Colony-Stimulating Factor to Mature Neutrophils from X-Irradiated Human Peripheral Blood Hematopoietic Progenitor Cells
  • Katsumori Takeo,Yoshino Hironori,Hayashi Masako,Takahashi Kenji,Kashiwakura Ikuo
  • Biological and Pharmaceutical Bulletin 32(11), 1849-1853, 2009
  • … Filgrastim, Nartograstim, and Lenograstim are clinically available in Japan. … however, Lenograstim is superior to others because of CFU-G-derived colony formation at relatively low doses. … In terms of functional characteristics of neutrophils, Lenograstim-induced neutrophils produced high levels of reactive oxygen species compared to Filgrastim, when rhG-CSF was applied to nonirradiated CD34+ cells. …
  • NAID 130000116956
  • 多発性骨髄腫患者における自己末梢血幹細胞の高効率な採取法
  • 安田 昌宏,坂井田 正光,加藤 博明,横山 裕子,棚橋 純子,下村 順子,高橋 健
  • 医療薬学 30(4), 280-287, 2004-04-10
  • … When the leukocyte count dropped below 1,000/μL, a granulocyte colony stimulating factor, lenograstim (7.1 ± 2.9μg/kg/day), was administered for around 7 days. …
  • NAID 110001171525


lenograstim Verifiedfields = changed | verifiedrevid = 447995983 | IUPAC_name = | image = | tradename = Euprotin, Granocyte, Lenobio, Neutrogin | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US ...
Abstract Lenograstim is the glycosylated recombinant form of human granulocyte colony stimulating factor. The drug is used to reduce the risk of life-threatening infection in patients ... Hollingshead LM, Goa KL. Recombinant ...